Spirit Biosciences Capital
- Investor (buy-side or sell-side research)
Biotech investment arm of a single-family office. We advise on approximately $150 million sector-dedicated capital. Seeking new investment opportunities. Specific mandate in clinical or near-clinical stage precision oncology therapeutics, but open to all indications.
Address
NorthrbookIllinois
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}